{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:59:15Z","timestamp":1773921555269,"version":"3.50.1"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/wnf.0b013e31815cd94c","type":"journal-article","created":{"date-parts":[[2008,11,24]],"date-time":"2008-11-24T08:11:17Z","timestamp":1227514277000},"page":"353-362","source":"Crossref","is-referenced-by-count":42,"title":["Role of Sildenafil in Neurological Disorders"],"prefix":"10.1097","volume":"31","author":[{"given":"Muhammad U.","family":"Farooq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharath","family":"Naravetla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip W.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshad","family":"Majid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounzer Y.","family":"Kassab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00004647-200209000-00010","article-title":"The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects.","volume":"22","author":"Kruuse","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/diacare.25.8.1336","article-title":"Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes.","volume":"25","author":"Desouza","year":"2002","journal-title":"Diabetes Care"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.wnl.0000173835.12308.bb","article-title":"Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study.","volume":"65","author":"Diomedi","year":"2005","journal-title":"Neurology"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1468-2982.2003.00712.x","article-title":"Plasma levels of cAMP, cGMP and CGRP in sildenafil-induced headache.","volume":"24","author":"Kruuse","year":"2004","journal-title":"Cephalalgia"},{"key":"R6-6-20210203","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.ijir.3900354","article-title":"Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction.","volume":"10","author":"Morales","year":"1998","journal-title":"Int J Impot Res"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"35C","DOI":"10.1016\/S0002-9149(99)00046-6","article-title":"Overall cardiovascular profile of sildenafil citrate.","volume":"83","author":"Zusman","year":"1999","journal-title":"Am J Cardiol"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0925-4927(03)00018-0","article-title":"Effect of sildenafil (Viagra) on cerebral blood flow velocity: a pilot study.","volume":"122","author":"Arnavaz","year":"2003","journal-title":"Psychiatry Res"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hep.20565","article-title":"Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts.","volume":"41","author":"Erceg","year":"2005","journal-title":"Hepatology"},{"key":"R11-6-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/00006123-198001000-00001","article-title":"Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.","volume":"6","author":"Fisher","year":"1980","journal-title":"Neurosurgery"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/01.wnl.0000182169.91597.6c","article-title":"Effect of sildenafil (Viagra) on cerebral blood vessels.","volume":"65","author":"Johnston","year":"2005","journal-title":"Neurology"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1468-2982.2002.00365.x","article-title":"Exaggerated interictal cerebrovascular reactivity but normal blood flow velocities in migraine without aura.","volume":"22","author":"Dora","year":"2002","journal-title":"Cephalalgia"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bmj.325.7369.869","article-title":"Tonic-clonic seizures in patients taking sildenafil.","volume":"325","author":"Gilad","year":"2002","journal-title":"BMJ"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bjp.0706680","article-title":"The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway.","volume":"147","author":"Riazi","year":"2006","journal-title":"Br J Pharmacol"},{"key":"R16-6-20210203","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0022-5347(01)63299-3","article-title":"Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.","volume":"159","author":"Ballard","year":"1998","journal-title":"J Urol"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1523\/JNEUROSCI.23-16-06452.2003","article-title":"Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.","volume":"23","author":"Shimizu-Albergine","year":"2003","journal-title":"J Neurosci"},{"key":"R18-6-20210203","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/bi00778a018","article-title":"Multiple cyclic nucleotide phosphodiesterase activities from rat brain.","volume":"10","author":"Thompson","year":"1971","journal-title":"Biochemistry"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1074\/jbc.M407521200","article-title":"Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium.","volume":"280","author":"Barnes","year":"2005","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/bj2830487","article-title":"The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung.","volume":"283","author":"Burns","year":"1992","journal-title":"Biochem J"},{"key":"R21-6-20210203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation.","volume":"100","author":"Omori","year":"2007","journal-title":"Circ Res"},{"key":"R22-6-20210203","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.0000258451.44949.d7","article-title":"Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart.","volume":"100","author":"Yan","year":"2007","journal-title":"Circ Res"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1540\/jsmr.41.1","article-title":"Regulation of cyclic nucleotides in the urinary tract.","volume":"41","author":"Wheeler","year":"2005","journal-title":"J Smooth Muscle Res"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1179\/016164102101200447","article-title":"Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model.","volume":"24","author":"Inoha","year":"2002","journal-title":"Neurol Res"},{"key":"R26-6-20210203","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000090555","article-title":"Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension.","volume":"21","author":"Rosengarten","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"R27-6-20210203","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/WNL.57.9.1730","article-title":"Transient ischemic attack and stroke associated with sildenafil (Viagra) use.","volume":"57","author":"Morgan","year":"2001","journal-title":"Neurology"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/01.WNF.0000220815.86478.5F","article-title":"PetravientityD. Stroke-an adverse reaction to sildenafil.","volume":"29","author":"Habek","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8","article-title":"Nitric Oxide in the pathogenesis of vascular disease.","volume":"190","author":"Li","year":"2000","journal-title":"J Pathol"},{"key":"R30-6-20210203","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00004647-199607000-00009","article-title":"ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats.","volume":"16","author":"Zhang","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"R31-6-20210203","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.1249","article-title":"A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats.","volume":"50","author":"Zhang","year":"2001","journal-title":"Ann Neurol"},{"key":"R32-6-20210203","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.RES.0000056757.93432.8C","article-title":"Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat.","volume":"92","author":"Zhang","year":"2003","journal-title":"Circ Res"},{"key":"R33-6-20210203","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0002-9440(10)61775-0","article-title":"Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.","volume":"159","author":"Bussolati","year":"2001","journal-title":"Am J Pathol"},{"key":"R34-6-20210203","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1006\/bbrc.1999.1729","article-title":"A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.","volume":"265","author":"Kroll","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"R35-6-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/02688690120072513","article-title":"Sildenafil (Viagra)-induced spontaneous intracerebral haemorrhage.","volume":"15","author":"Buxton","year":"2001","journal-title":"Br J Neurosurg"},{"key":"R36-6-20210203","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s004150170250","article-title":"Intracerebral haemorrhage associated with sildenafil citrate.","volume":"248","author":"Monastero","year":"2001","journal-title":"J Neurol"},{"key":"R37-6-20210203","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1212\/01.WNL.0000130359.58099.8B","article-title":"Hemiballism due to sildenafil use.","volume":"63","author":"Marti","year":"2004","journal-title":"Neurology"},{"key":"R38-6-20210203","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9394(98)00243-8","article-title":"Pupil-sparing third nerve palsy associated with sildenafil citrate (Viagra).","volume":"126","author":"Donahue","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R39-6-20210203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1743-6109.2005.00194.x","article-title":"Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction.","volume":"3","author":"Laties","year":"2006","journal-title":"J Sex Med"},{"key":"R40-6-20210203","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.STR.0000116869.64771.5A","article-title":"Blood pressure and stroke: an overview of published reviews.","volume":"35","author":"Lawes","year":"2004","journal-title":"Stroke"},{"key":"R41-6-20210203","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0022-5347(01)63299-3","article-title":"Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.","volume":"159","author":"Ballard","year":"1998","journal-title":"J Urol"},{"key":"R42-6-20210203","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"R43-6-20210203","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1212\/01.wnl.0000224699.75283.18","article-title":"Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study.","volume":"66","author":"Brenner","year":"2006","journal-title":"Neurology"},{"key":"R44-6-20210203","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1468-2982.2006.01071.x","article-title":"Figuerola, M, Bruera O, Leston J, et al. Cluster headache attack due to sildenafil intake.","volume":"26","year":"2006","journal-title":"Cephalalgia"},{"key":"R45-6-20210203","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1526-4610.2006.00316_4.x","article-title":"Sildenafil can trigger cluster headaches.","volume":"46","author":"Evans","year":"2006","journal-title":"Headache"},{"key":"R46-6-20210203","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1179\/016164102101200447","article-title":"Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model.","volume":"24","author":"Inoha","year":"2002","journal-title":"Neurol Res"},{"key":"R47-6-20210203","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.STR.27.3.544","article-title":"Risk factors for subarachnoid hemorrhage: a systematic review.","volume":"27","author":"Teunissen","year":"1996","journal-title":"Stroke"},{"key":"R48-6-20210203","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/jama.281.12.1112","article-title":"Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association.","volume":"281","author":"Gorelick","year":"1999","journal-title":"JAMA"},{"key":"R49-6-20210203","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00003246-199506000-00004","article-title":"Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study.","volume":"23","author":"Solenski","year":"1995","journal-title":"Crit Care Med"},{"key":"R50-6-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ncl.2003.12.002","article-title":"Subarachnoid hemmorhage.","volume":"22","author":"Manno","year":"2004","journal-title":"Neurol Clin"},{"key":"R51-6-20210203","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/01.STR.0000020121.41527.5D","article-title":"Hemoglobin-induced cytotoxicity in rat cerebral cortical neurons: caspase activation and oxidative stress.","volume":"33","author":"Wang","year":"2002","journal-title":"Stroke"},{"key":"R52-6-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10072-003-0102-6","article-title":"Sildenafil and transient global amnesia.","volume":"24","author":"Gandolfo","year":"2003","journal-title":"Neurol Sci"},{"key":"R53-6-20210203","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/WNL.59.5.778","article-title":"Transient global amnesia after sildenafil (Viagra) use.","volume":"59","author":"Savitz","year":"2002","journal-title":"Neurology"},{"key":"R54-6-20210203","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.ijir.3901301","article-title":"Transient global amnesia after intake of tadalafil, a PDE-5 inhibitor: a possible association?","volume":"17","author":"Schiefer","year":"2005","journal-title":"Int J Impot Res"},{"key":"R55-6-20210203","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-005-0232-z","article-title":"Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition.","volume":"183","author":"Devan","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R56-6-20210203","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.pbb.2004.09.019","article-title":"Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats.","volume":"79","author":"Devan","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"R57-6-20210203","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/jnnp.2004.038695","article-title":"A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis.","volume":"76","author":"Fowler","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R58-6-20210203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-4943(02)00124-3","article-title":"Sildenafil in the treatment of erectile dysfunction in elderly depressed patients with idiopathic Parkinson's disease.","volume":"8","author":"Giammusso","year":"2002","journal-title":"Arch Gerontol Geriatr Suppl"},{"key":"R59-6-20210203","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","article-title":"Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension.","volume":"71","author":"Hussain","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R60-6-20210203","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0021-9258(18)89770-8","article-title":"cGMP phosphodiesterase in rod and cone outer segments of the retina.","volume":"260","author":"Hurwitz","year":"1985","journal-title":"J Biol Chem"},{"key":"R61-6-20210203","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(98)05473-7","article-title":"Retinal side-effects of sildenafil.","volume":"353","author":"Vobig","year":"1999","journal-title":"Lancet"},{"key":"R62-6-20210203","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/bjo.84.8.928g","article-title":"Branch retinal artery occlusion; another complication of sildenafil.","volume":"84","author":"Tripathi","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R63-6-20210203","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJM200006013422218","article-title":"Sildenafil and ocular perfusion.","volume":"342","author":"Sponsel","year":"2000","journal-title":"N Engl J Med"},{"key":"R64-6-20210203","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0140-6736(05)75965-1","article-title":"Retinal side-effects of sildenafil.","volume":"353","author":"Vobig","year":"1999","journal-title":"Lancet"},{"key":"R65-6-20210203","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0002-9394(02)01338-7","article-title":"A double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (Viagra) on visual function in subjects with early-stage age-related macular degeneration.","volume":"133","author":"Birch","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R66-6-20210203","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00041327-200103000-00006","article-title":"Anterior ischemic optic neuropathy associated with viagra.","volume":"21","author":"Cunningham","year":"2001","journal-title":"J Neuroophthalmol"},{"key":"R67-6-20210203","first-page":"291","article-title":"Sildenafil (Viagra) associated anterior ischemic optic neuropathy.","volume":"118","author":"Egan","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R68-6-20210203","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0161-6420(01)00976-9","article-title":"Sildenafil-associated nonarteritic anterior ischemic optic neuropathy.","volume":"109","author":"Pomeranz","year":"2002","journal-title":"Ophthalmology"},{"key":"R69-6-20210203","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archopht.124.5.733","article-title":"Nonarteritic anterior ischemic optic neuropathy and sildenafil.","volume":"124","author":"Fraunfelder","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R71-6-20210203","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1368-5031.2006.00904.x","article-title":"Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy.","volume":"60","author":"Gorkin","year":"2006","journal-title":"Int J Clin Pract"},{"key":"R72-6-20210203","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/jnnp.2004.038695","article-title":"A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis.","volume":"76","author":"Fowler","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R73-6-20210203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/1531-8249(199907)46:1<15::AID-ANA5>3.0.CO;2-U","article-title":"Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Sildenafil Study Group.","volume":"46","author":"Giuliano","year":"1999","journal-title":"Ann Neurol"},{"key":"R74-6-20210203","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1531-8257(200003)15:2<305::AID-MDS1015>3.0.CO;2-W","article-title":"Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease.","volume":"15","author":"Zesiewicz","year":"2000","journal-title":"Mov Disord"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002826-200811000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:51:48Z","timestamp":1618278708000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-200811000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31815cd94c","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}